IE 11 is not supported. For an optimal experience visit our site on another browser.

Trial of new Alzheimer’s drug shows promising signs in slowing dementia


NBC News medical correspondent Dr. John Torres joins TODAY to talk about a new trial on a breakthrough Alzheimer’s medication from Eisai, a Japanese partner to the company Biogen. “This (drug) not only influences the structural changes to the brain, but also helps reduce memory decline over 18 months of the study,” Torres says.